Trials / Completed
CompletedNCT02205359
AdaptResponse Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3,797 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical study is to test the hypothesis that market released Cardiac Resynchronization Therapy (CRT) devices which contain the AdaptivCRT® (aCRT) algorithm have a superior outcome compared to standard CRT devices in CRT indicated patients with normal atrio-ventricular (AV) conduction and left bundle branch block (LBBB).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | aCRT ON | CRT device with AdaptivCRT enabled (AdaptivBiV and LV) |
| DEVICE | aCRT OFF | CRT device with AdaptivCRT disabled |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2022-11-02
- Completion
- 2022-11-02
- First posted
- 2014-07-31
- Last updated
- 2023-11-29
- Results posted
- 2023-11-29
Locations
220 sites across 28 countries: United States, Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Norway, Poland, Portugal, Puerto Rico, Russia, Saudi Arabia, Slovakia, South Korea, Spain, Sweden, Switzerland, Taiwan, United Kingdom
Source: ClinicalTrials.gov record NCT02205359. Inclusion in this directory is not an endorsement.